{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:24:13Z","timestamp":1791894253681,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7337","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1038\/nature09730","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T09:57:42Z","timestamp":1299578262000},"page":"189-195","source":"Crossref","is-referenced-by-count":884,"title":["Inactivating mutations of acetyltransferase genes in B-cell lymphoma"],"prefix":"10.1038","volume":"471","author":[{"given":"Laura","family":"Pasqualucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dominguez-Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Chiarenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina","family":"Grunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Trifonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawryn H.","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Lerach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Chadburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vundavalli V.","family":"Murty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Mullighan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Gaidano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Rabadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K.","family":"Brindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Dalla-Favera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,9]]},"reference":[{"key":"BFnature09730_CR1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow, S. H. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (International Agency for Research on Cancer (IARC), Lyon, 2008)"},{"key":"BFnature09730_CR2","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nature07968","volume":"459","author":"M Compagno","year":"2009","unstructured":"Compagno, M. et al. Mutations of multiple genes cause deregulation of NF-\u03baB in diffuse large B-cell lymphoma. Nature 459, 717\u2013721 (2009)","journal-title":"Nature"},{"key":"BFnature09730_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature08638","volume":"463","author":"RE Davis","year":"2010","unstructured":"Davis, R. E. et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463, 88\u201392 (2010)","journal-title":"Nature"},{"key":"BFnature09730_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri2217","volume":"8","author":"U Klein","year":"2008","unstructured":"Klein, U. & Dalla-Favera, R. Germinal centres: role in B-cell physiology and malignancy. Nature Rev. Immunol. 8, 22\u201333 (2008)","journal-title":"Nature Rev. Immunol."},{"key":"BFnature09730_CR5","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1126\/science.1153629","volume":"319","author":"G Lenz","year":"2008","unstructured":"Lenz, G. et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319, 1676\u20131679 (2008)","journal-title":"Science"},{"key":"BFnature09730_CR6","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMra0807082","volume":"362","author":"G Lenz","year":"2010","unstructured":"Lenz, G. & Staudt, L. M. Aggressive lymphomas. N. Engl. J. Med. 362, 1417\u20131429 (2010)","journal-title":"N. Engl. J. Med."},{"key":"BFnature09730_CR7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ccr.2010.10.030","volume":"18","author":"J Mandelbaum","year":"2010","unstructured":"Mandelbaum, J. BLIMP1 is a tumor suppressor gene frequently disrupted in activated B-cell like diffuse large B-cell lymphoma. Cancer Cell 18, 568\u2013579 (2010)","journal-title":"Cancer Cell"},{"key":"BFnature09730_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ng.518","volume":"42","author":"RD Morin","year":"2010","unstructured":"Morin, R. D. et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nature Genet. 42, 181\u2013185 (2010)","journal-title":"Nature Genet."},{"key":"BFnature09730_CR9","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMe0906090","volume":"361","author":"JR Downing","year":"2009","unstructured":"Downing, J. R. Cancer genomes\u2014continuing progress. N. Engl. J. Med. 361, 1111\u20131112 (2009)","journal-title":"N. Engl. J. Med."},{"key":"BFnature09730_CR10","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1101\/gad.14.13.1553","volume":"14","author":"RH Goodman","year":"2000","unstructured":"Goodman, R. H. & Smolik, S. CBP\/p300 in cell growth, transformation, and development. Genes Dev. 14, 1553\u20131577 (2000)","journal-title":"Genes Dev."},{"key":"BFnature09730_CR11","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.bcp.2004.03.045","volume":"68","author":"E Kalkhoven","year":"2004","unstructured":"Kalkhoven, E. CBP and p300: HATs for different occasions. Biochem. Pharmacol. 68, 1145\u20131155 (2004)","journal-title":"Biochem. Pharmacol."},{"key":"BFnature09730_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/384641a0","volume":"384","author":"AJ Bannister","year":"1996","unstructured":"Bannister, A. J. & Kouzarides, T. The CBP co-activator is a histone acetyltransferase. Nature 384, 641\u2013643 (1996)","journal-title":"Nature"},{"key":"BFnature09730_CR13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0092-8674(00)82001-2","volume":"87","author":"VV Ogryzko","year":"1996","unstructured":"Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H. & Nakatani, Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953\u2013959 (1996)","journal-title":"Cell"},{"key":"BFnature09730_CR14","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/42972","volume":"387","author":"W Gu","year":"1997","unstructured":"Gu, W., Shi, X. L. & Roeder, R. G. Synergistic activation of transcription by CBP and p53. Nature 387, 819\u2013823 (1997)","journal-title":"Nature"},{"key":"BFnature09730_CR15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/42981","volume":"387","author":"NL Lill","year":"1997","unstructured":"Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J. & Livingston, D. M. Binding and modulation of p53 by p300\/CBP coactivators. Nature 387, 823\u2013827 (1997)","journal-title":"Nature"},{"key":"BFnature09730_CR16","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0092-8674(00)80304-9","volume":"89","author":"ML Avantaggiati","year":"1997","unstructured":"Avantaggiati, M. L. et al. Recruitment of p300\/CBP in p53-dependent signal pathways. Cell 89, 1175\u20131184 (1997)","journal-title":"Cell"},{"key":"BFnature09730_CR17","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1073\/pnas.95.5.2061","volume":"95","author":"GA Blobel","year":"1998","unstructured":"Blobel, G. A., Nakajima, T., Eckner, R., Montminy, M. & Orkin, S. H. CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation. Proc. Natl Acad. Sci. USA 95, 2061\u20132066 (1998)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature09730_CR18","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/ng1018","volume":"32","author":"OR Bereshchenko","year":"2002","unstructured":"Bereshchenko, O. R., Gu, W. & Dalla-Favera, R. Acetylation inactivates the transcriptional repressor BCL6. Nature Genet. 32, 606\u2013613 (2002)","journal-title":"Nature Genet."},{"key":"BFnature09730_CR19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1126\/science.1080386","volume":"300","author":"SR Grossman","year":"2003","unstructured":"Grossman, S. R. et al. Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300, 342\u2013344 (2003)","journal-title":"Science"},{"key":"BFnature09730_CR20","doi-asserted-by":"publisher","first-page":"16275","DOI":"10.1073\/pnas.0904305106","volume":"106","author":"D Shi","year":"2009","unstructured":"Shi, D. et al. CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53. Proc. Natl Acad. Sci. USA 106, 16275\u201316280 (2009)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature09730_CR21","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1182\/blood.V93.9.2771","volume":"93","author":"Y Oike","year":"1999","unstructured":"Oike, Y. et al. Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. Blood 93, 2771\u20132779 (1999)","journal-title":"Blood"},{"key":"BFnature09730_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0092-8674(00)81165-4","volume":"93","author":"TP Yao","year":"1998","unstructured":"Yao, T. P. et al. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93, 361\u2013372 (1998)","journal-title":"Cell"},{"key":"BFnature09730_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399407000415","volume":"9","author":"JH Roelfsema","year":"2007","unstructured":"Roelfsema, J. H. & Peters, D. J. Rubinstein-Taybi syndrome: clinical and molecular overview. Expert Rev. Mol. Med. 9, 1\u201316 (2007)","journal-title":"Expert Rev. Mol. Med."},{"key":"BFnature09730_CR24","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/376348a0","volume":"376","author":"F Petrif","year":"1995","unstructured":"Petrif, F. et al. Rubinstein\u2013Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376, 348\u2013351 (1995)","journal-title":"Nature"},{"key":"BFnature09730_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ajmg.1320560125","volume":"56","author":"RW Miller","year":"1995","unstructured":"Miller, R. W. & Rubinstein, J. H. Tumors in Rubinstein-Taybi syndrome. Am. J. Med. Genet. 56, 112\u2013115 (1995)","journal-title":"Am. J. Med. Genet."},{"key":"BFnature09730_CR26","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1038\/sj.onc.1207118","volume":"23","author":"NG Iyer","year":"2004","unstructured":"Iyer, N. G., Ozdag, H. & Caldas, C. p300\/CBP and cancer. Oncogene 23, 4225\u20134231 (2004)","journal-title":"Oncogene"},{"key":"BFnature09730_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/73536","volume":"24","author":"SA Gayther","year":"2000","unstructured":"Gayther, S. A. et al. Mutations truncating the EP300 acetylase in human cancers. Nature Genet. 24, 300\u2013303 (2000)","journal-title":"Nature Genet."},{"key":"BFnature09730_CR28","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1136\/jmg.2004.025080","volume":"42","author":"R Ward","year":"2005","unstructured":"Ward, R., Johnson, M., Shridhar, V., van Deursen, J. & Couch, F. J. CBP truncating mutations in ovarian cancer. J. Med. Genet. 42, 514\u2013518 (2005)","journal-title":"J. Med. Genet."},{"key":"BFnature09730_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.canlet.2009.10.018","volume":"291","author":"MR Garbati","year":"2010","unstructured":"Garbati, M. R., Alco, G. & Gilmore, T. D. Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8. Cancer Lett. 291, 237\u2013245 (2010)","journal-title":"Cancer Lett."},{"key":"BFnature09730_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0304-3835(03)00442-7","volume":"213","author":"K Shigeno","year":"2004","unstructured":"Shigeno, K. et al. Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemias. Cancer Lett. 213, 11\u201320 (2004)","journal-title":"Cancer Lett."},{"key":"BFnature09730_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ng0996-33","volume":"14","author":"J Borrow","year":"1996","unstructured":"Borrow, J. et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nature Genet. 14, 33\u201341 (1996)","journal-title":"Nature Genet."},{"key":"BFnature09730_CR32","first-page":"535","volume":"90","author":"JD Rowley","year":"1997","unstructured":"Rowley, J. D. et al. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Blood 90, 535\u2013541 (1997)","journal-title":"Blood"},{"key":"BFnature09730_CR33","doi-asserted-by":"publisher","first-page":"8732","DOI":"10.1073\/pnas.94.16.8732","volume":"94","author":"OM Sobulo","year":"1997","unstructured":"Sobulo, O. M. et al. MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc. Natl Acad. Sci. USA 94, 8732\u20138737 (1997)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature09730_CR34","unstructured":"Mullighan, C. G. et al. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 10.1038\/nature09727 (this issue)"},{"key":"BFnature09730_CR35","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nature06546","volume":"451","author":"X Liu","year":"2008","unstructured":"Liu, X. et al. The structural basis of protein acetylation by the p300\/CBP transcriptional coactivator. Nature 451, 846\u2013850 (2008)","journal-title":"Nature"},{"key":"BFnature09730_CR36","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nature03147","volume":"432","author":"RT Phan","year":"2004","unstructured":"Phan, R. T. & Dalla-Favera, R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432, 635\u2013639 (2004)","journal-title":"Nature"},{"key":"BFnature09730_CR37","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.cell.2008.03.025","volume":"133","author":"Y Tang","year":"2008","unstructured":"Tang, Y., Zhao, W., Chen, Y., Zhao, Y. & Gu, W. Acetylation is indispensable for p53 activation. Cell 133, 612\u2013626 (2008)","journal-title":"Cell"},{"key":"BFnature09730_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/370223a0","volume":"370","author":"RP Kwok","year":"1994","unstructured":"Kwok, R. P. et al. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370, 223\u2013226 (1994)","journal-title":"Nature"},{"key":"BFnature09730_CR39","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1038\/emboj.2010.235","volume":"29","author":"LH Kasper","year":"2010","unstructured":"Kasper, L. H. et al. CBP\/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation. EMBO J. 29, 3660\u20133672 (2010)","journal-title":"EMBO J."},{"key":"BFnature09730_CR40","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1093\/nar\/29.21.4462","volume":"29","author":"L Bordoli","year":"2001","unstructured":"Bordoli, L. et al. Functional analysis of the p300 acetyltransferase domain: the PHD finger of p300 but not of CBP is dispensable for enzymatic activity. Nucleic Acids Res. 29, 4462\u20134471 (2001)","journal-title":"Nucleic Acids Res."},{"key":"BFnature09730_CR41","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1182\/blood-2005-08-3263","volume":"107","author":"W Xu","year":"2006","unstructured":"Xu, W. et al. Global transcriptional coactivators CREB-binding protein and p300 are highly essential collectively but not individually in peripheral B cells. Blood 107, 4407\u20134416 (2006)","journal-title":"Blood"},{"key":"BFnature09730_CR42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1101\/gad.14.3.272","volume":"14","author":"AL Kung","year":"2000","unstructured":"Kung, A. L. et al. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev. 14, 272\u2013277 (2000)","journal-title":"Genes Dev."},{"key":"BFnature09730_CR43","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/sj.embor.embor941","volume":"4","author":"G Legube","year":"2003","unstructured":"Legube, G. & Trouche, D. Regulating histone acetyltransferases and deacetylases. EMBO Rep. 4, 944\u2013947 (2003)","journal-title":"EMBO Rep."},{"key":"BFnature09730_CR44","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/ni1245","volume":"6","author":"RT Phan","year":"2005","unstructured":"Phan, R. T., Saito, M., Basso, K., Niu, H. & Dalla-Favera, R. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nature Immunol. 6, 1054\u20131060 (2005)","journal-title":"Nature Immunol."},{"key":"BFnature09730_CR45","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/annonc\/mdn792","volume":"20","author":"L Stimson","year":"2009","unstructured":"Stimson, L., Wood, V., Khan, O., Fotheringham, S. & La Thangue, N. B. HDAC inhibitor-based therapies and haematological malignancy. Ann. Oncol. 20, 1293\u20131302 (2009)","journal-title":"Ann. Oncol."},{"key":"BFnature09730_CR46","doi-asserted-by":"publisher","first-page":"74\u201377,","DOI":"10.2144\/01301st03","volume":"30","author":"T Bieber","year":"2001","unstructured":"Bieber, T. & Elsasser, H. P. Preparation of a low molecular weight polyethylenimine for efficient cell transfection. Biotechniques 30, 74\u201377,\u201380\u201381 (2001)","journal-title":"Biotechniques"},{"key":"BFnature09730_CR47","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1101\/gad.14.14.1810","volume":"14","author":"KD Huynh","year":"2000","unstructured":"Huynh, K. D., Fischle, W., Verdin, E. & Bardwell, V. J. BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev. 14, 1810\u20131823 (2000)","journal-title":"Genes Dev."},{"key":"BFnature09730_CR48","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jbiotec.2007.07.498","volume":"131","author":"D Kuninger","year":"2007","unstructured":"Kuninger, D., Lundblad, J., Semirale, A. & Rotwein, P. A non-isotopic in vitro assay for histone acetylation. J. Biotechnol. 131, 253\u2013260 (2007)","journal-title":"J. Biotechnol."},{"key":"BFnature09730_CR49","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.molcel.2006.11.021","volume":"24","author":"Y Tang","year":"2006","unstructured":"Tang, Y., Luo, J., Zhang, W. & Gu, W. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol. Cell 24, 827\u2013839 (2006)","journal-title":"Mol. Cell"},{"key":"BFnature09730_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4161\/epi.5.1.10449","volume":"5","author":"DC Bedford","year":"2010","unstructured":"Bedford, D. C., Kasper, L. H., Fukuyama, T. & Brindle, P. K. Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases. Epigenetics 5, 9\u201315 (2010)","journal-title":"Epigenetics"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature09730.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature09730","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature09730.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:49:46Z","timestamp":1684417786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature09730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":50,"journal-issue":{"issue":"7337","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["BFnature09730"],"URL":"https:\/\/doi.org\/10.1038\/nature09730","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.8990963.9553062","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}